BioNTech SE (BNTX) Equity Ratio (2018 - 2021)

BioNTech SE has disclosed Equity Ratio across 4 years of filings, most recently posting 0.75 for Q4 2021.

• Equity Ratio for Q4 2021 came in at 0.75, up 26.98% year-over-year; the trailing twelve-month figure through Dec 2021 was 0.75 (up 26.98% YoY), and the FY2021 annual result was 0.75, up 26.98% from the prior year.
• Equity Ratio came in at 0.75 for Q4 2021 at BioNTech SE, up from 0.59 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.75 in Q4 2021 to a low of 0.41 in Q4 2018.
• The 4-year median for Equity Ratio is 0.59 (2020), against an average of 0.59.
• Across the five-year window, Equity Ratio jumped 51.31% in 2019 and declined 4.37% in 2020, its largest moves.
• BioNTech SE's Equity Ratio stood at 0.41 in 2018, then jumped by 51.31% to 0.62 in 2019, then slipped by 4.37% to 0.59 in 2020, then climbed by 26.98% to 0.75 in 2021.
• The last three Equity Ratio figures came in at 0.75 (Q4 2021), 0.59 (Q4 2020), and 0.62 (Q4 2019), per Business Quant data.